A Citigroup spokesperson told Stocktwits that layoffs reflect adjustments Citi is making to ensure its staffing levels, locations and expertise align with current business needs.
The company’s U.S. affiliate announced that the U.S. Food and Drug Administration has approved a generic version of Liraglutide injection, known as Saxenda.